Sign Up Today and Learn More About Grail Stock
Invest in or calculate the value of your shares in Grail or other pre-IPO companies through EquityZen's platform.
About Grail Stock
Founded
2012
Headquarters
Menlo Park, CA, US
Notable Investor
Sequoia Capital China
Total Funding
1.9B
Industries
Grail develops a pan-cancer screening test designed to detect cancer early. Its pan-cancer screening test measures circulating nucleic acids in blood using high-intensity sequencing, population-scale clinical trials, enabling doctors to develop blood tests for early-stage cancer detection.
Grail Press Mentions
Stay in the know about the latest news on Grail
Grail kicks off its first study to provide doctors with real-world results from its multi-cancer blood test
fiercebiotech • Feb 18, 2020
Early cancer-detection startup Grail is reportedly trying to raise more money
TechCrunch • Nov 01, 2017
Grail is raising at least $1 billion to fund its early cancer screening test
TechCrunch • Jan 06, 2017
Investors in Grail
Discover investors in Grail stock and explore their portfolio companies
Grail Management
Leadership team at Grail
Chief Executive Officer
Hans Bishop
Chief Operating Officer & Chief Financial Officer
Matthew Young
Join now and verify your accreditation status to gain access to:
- Grail current valuation
- Grail stock price
- Available deals in Grail and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Grail stock?
Accredited investors can buy pre-IPO stock in companies like Grail through EquityZen funds. These investments are made available by existing Grail shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Grail stock?
Shareholders can sell their Grail stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
